Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven®)
Nicole S Bartosh, Tara Tomlin, Christian Cable, Kathleen HalkaDepartment of Internal Medicine, Division of Medical Oncology, Scott and White Healthcare and Texas A and M Health Science Center College of Medicine, Temple, TX, USAAbstract: This case report presents a newly diagnosed congenital factor...
Enregistré dans:
Auteurs principaux: | Bartosh NS, Tomlin T, Cable C, Halka K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b4bf932b092349148cf13a2e0d2f0491 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia
par: Amir M. Ansari, et autres
Publié: (2021) -
Novanglus, No. VII
Publié: (2017) -
Resolución 130(VII): Energía nuclear = Resolution 130(VII): Nuclear energy = Résolution 130(VII): Energie nucléaire
Publié: (2014) -
Resolución 125(VII): Asistencia técnica = Resolution 125(VII): Technical assistance = Résolution 125(VII): Assistance technique
Publié: (2014) -
Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging
par: Liu H, et autres
Publié: (2016)